A Quick Options Activity Update
Wednesday, June 02, 2010
Among the stocks to watch, Amgen (AMGN) is trading up 4.4 percent after the FDA approved Prolia, a treatment for osteoporosis.
Monsanto (MON) rose more than 4 percent after being added to the Conviction Buy List at Goldman Sachs.
SPECIAL DISCOUNTED MEMBERSHIP RATES UNTIL JUNE 30, 2010